Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SYK |
---|---|---|
09:32 ET | 19884 | 334.25 |
09:34 ET | 2116 | 333.26 |
09:36 ET | 4155 | 332.94 |
09:38 ET | 8160 | 334.71 |
09:39 ET | 1300 | 333.895 |
09:41 ET | 1752 | 334.305 |
09:43 ET | 2201 | 333.75 |
09:45 ET | 1500 | 333.445 |
09:48 ET | 1400 | 332.91 |
09:50 ET | 2401 | 332.54 |
09:52 ET | 2504 | 332.475 |
09:54 ET | 1032 | 331.97 |
09:56 ET | 2575 | 332.955 |
09:59 ET | 601 | 332.53 |
10:01 ET | 1722 | 332.12 |
10:03 ET | 826 | 331.88 |
10:06 ET | 1600 | 332.88 |
10:08 ET | 500 | 332.73 |
10:10 ET | 333 | 332.82 |
10:12 ET | 500 | 332.64 |
10:14 ET | 2057 | 333.14 |
10:15 ET | 405 | 332.87 |
10:17 ET | 2980 | 332.53 |
10:19 ET | 2505 | 332.46 |
10:21 ET | 2195 | 332.6 |
10:24 ET | 1000 | 332.87 |
10:26 ET | 756 | 332.49 |
10:28 ET | 700 | 332.67 |
10:30 ET | 900 | 333.065 |
10:32 ET | 950 | 333.37 |
10:33 ET | 100 | 333.45 |
10:35 ET | 939 | 333.06 |
10:37 ET | 1083 | 333.26 |
10:39 ET | 557 | 333.255 |
10:42 ET | 500 | 333.17 |
10:44 ET | 300 | 333.17 |
10:46 ET | 500 | 333.24 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Stryker Corp | 127.4B | 38.1x | +9.49% |
Medtronic PLC | 99.2B | 28.1x | -4.17% |
Becton Dickinson and Co | 66.3B | 48.5x | +11.04% |
Abbott Laboratories | 179.5B | 31.9x | +18.64% |
Dexcom Inc | 44.7B | 72.7x | --- |
IDEXX Laboratories Inc | 39.4B | 46.0x | +18.62% |
Stryker Corporation (Stryker) is a medical technology company. The Company offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. It operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. Stryker is also engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. It also offers Fortress, a modular wall system for hospitals and ambulatory surgery centers.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $127.4B |
---|---|
Revenue (TTM) | $21.0B |
Shares Outstanding | 380.9M |
Dividend Yield | 0.96% |
Annual Dividend Rate | 3.2000 USD |
Ex-Dividend Date | 06-28-24 |
Pay Date | 07-31-24 |
Beta | 0.90 |
EPS | $8.75 |
Book Value | $48.92 |
P/E Ratio | 38.1x |
Price/Sales (TTM) | 6.1 |
Price/Cash Flow (TTM) | 29.0x |
Operating Margin | 19.68% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.